Product
EC
2 clinical trials
3 indications
Indication
NeutropeniaIndication
Breast CancerIndication
TuberculosisClinical trial
A Single-Center, Open-Label, Dose-Escalation Phase I Clinical Trial of Recombinant Human Granulocyte Colony Stimulating Factor-Fc Fusion Protein for Injection as an Adjuvant to Chemotherapy in Subjects With Breast CancerStatus: Completed, Estimated PCD: 2013-12-01
Clinical trial
Phase 2 Clinical Trial of Randomized, Blinded, Positive-controlled to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.Status: Recruiting, Estimated PCD: 2024-05-30